Mutations in the AXIN1 Gene in Advanced Prostate Cancer

European Urology

Volumn 56, Issue 3, 2009, Pages 486-494

  Yardy, George W ^a,b   Bicknell, David C ^a   Wilding, Jennifer L ^a   Bartlett, Sylvia ^a   Liu, Ying ^a   Winney, Bruce ^a   Turner, Gareth D H ^c   Brewster, Simon F ^b   Bodmer, Walter F ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

catenin; APC; Axin; Prostate cancer; Wnt signalling

Indexed keywords

APC PROTEIN; AXIN; BETA CATENIN; DNA; WNT PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; AXIN1 GENE; CANCER CELL CULTURE; CARCINOGENESIS; CLINICAL ARTICLE; DNA SEQUENCE; EMBRYO DEVELOPMENT; ENDOMETRIUM CANCER; GENE; GENE AMPLIFICATION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE CANCER; LASER MICRODISSECTION; LIVER CELL CARCINOMA; MALE; MEDULLOBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; STEM CELL; STOMACH CANCER;

AGED; AGED, 80 AND OVER; BETA CATENIN; GENES, APC; HUMANS; MALE; MIDDLE AGED; MUTATION; PROSTATIC NEOPLASMS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 67651062343     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.05.029     Document Type: Article

References (31)

1. Powell S.M., Zilz N., Beazer-Barclay Y., et al. APC mutations occur early during colorectal tumorigenesis. Nature 359 (1992) 235-237
2. Bodmer W.F., Bailey C.J., Bodmer J., et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328 (1987) 614-616
3. Ilyas M., Tomlinson I.P., Rowan A., Pignatelli M., and Bodmer W.F. Beta-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci U S A 94 (1997) 10330-10334
4. Fukuchi T., Sakamoto M., Tsuda H., Maruyama K., Nozawa S., and Hirohashi S. Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res 58 (1998) 3526-3528
5. Palacios J., and Gamallo C. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res 58 (1998) 1344-1347
6. Park W.S., Oh R.R., Park J.Y., et al. Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res 59 (1999) 4257-4260
7. Miyoshi Y., Iwao K., Nagasawa Y., et al. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 58 (1998) 2524-2527
8. Sunaga N., Kohno T., Kolligs F.T., Fearon E.R., Saito R., and Yokota J. Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma. Genes Chromosomes Cancer 30 (2001) 316-321
9. Ishizaki Y., Ikeda S., Fujimori M., et al. Immunohistochemical analysis and mutational analyses of beta-catenin. Axin family and APC genes in hepatocellular carcinomas. Int J Oncol 24 (2004) 1077-1083
10. Taniguchi K., Roberts L.R., Aderca I.N., et al. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21 (2002) 4863-4871
11. Dahmen R.P., Koch A., Denkhaus D., et al. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 61 (2001) 7039-7043
12. Wu R., Zhai Y., Fearon E.R., and Cho K.R. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res 61 (2001) 8247-8255
13. Taplin M.E., Bubley G.J., Shuster T.D., et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332 (1995) 1393-1398
14. Visakorpi T., Hyytinen E., Koivisto P., et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9 (1995) 401-406
15. Chen C.D., Welsbie D.S., Tran C., et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med 10 (2004) 33-39
16. Truica C.I., Byers S., and Gelmann E.P. Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res 60 (2000) 4709-4713
17. Yang F., Li X., Sharma M., et al. Linking beta-catenin to androgen-signaling pathway. J Biol Chem 277 (2002) 11336-11344
18. Mulholland D.J., Read J.T., Rennie P.S., Cox M.E., and Nelson C.C. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis. Oncogene 22 (2003) 5602-5613
19. Yang X., Chen M.W., Terry S., et al. Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells. Oncogene 25 (2006) 3436-3444
20. Brewster S.F., Browne S., and Brown K.W. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma. J Urol 151 (1994) 1073-1077
21. Watanabe M., Kakiuchi H., Kato H., et al. APC gene mutations in human prostate cancer. Jpn J Clin Oncol 26 (1996) 77-81
22. Voeller H.J., Truica C.I., and Gelmann E.P. Beta-catenin mutations in human prostate cancer. Cancer Res 58 (1998) 2520-2523
23. Chesire D.R., Ewing C.M., Sauvageot J., Bova G.S., and Isaacs W.B. Detection and analysis of beta-catenin mutations in prostate cancer. Prostate 45 (2000) 323-334
24. Gerstein A.V., Almeida T.A., Zhao G., et al. APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers. Genes Chromosomes Cancer 34 (2002) 9-16
25. de la Taille A., Rubin M.A., Chen M.W., et al. Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells. Clin Cancer Res 9 (2003) 1801-1807
26. Miyoshi Y., Nagase H., Ando H., et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1 (1992) 229-233
27. Polakis P. Wnt signaling and cancer. Genes Dev 14 (2000) 1837-1851
28. Bruxvoort K.J., Charbonneau H.M., Giambernardi T.A., et al. Inactivation of APC in the mouse prostate causes prostate carcinoma. Cancer Res 67 (2007) 2490-2496
29. Salahshor S., and Woodgett J.R. The links between axin and carcinogenesis. J Clin Pathol 58 (2005) 225-236
30. Waltering K.K., Wallen M.J., Tammela T.L., Vessella R.L., and Visakorpi T. Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer. Prostate 66 (2006) 1585-1591
31. Suriano G., Vrcelj N., Senz J., et al. Beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer. Genes Chromosomes Cancer 42 (2005) 238-246